SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)

NCT00102739 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Purpura, Thrombocytopaenic, Idiopathic

Interventions

DRUG: SB497115

Sponsor

GlaxoSmithKline